Search Results - "Tassano, Marcos R."

[ 177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies by Audicio, Paola F., Castellano, Gustavo, Tassano, Marcos R., Rezzano, Maria E., Fernandez, Marcelo, Riva, Eloisa, Robles, Ana, Cabral, Pablo, Balter, Henia, Oliver, Patricia

“…Anti-CD20 (Rituximab ®), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin's Lymphoma, was conjugated to a bifunctional quelate (DOTA)…”
Get full text

Development of 99mTc(CO)3-dendrimer-FITC for cancer imaging by Tassano, Marcos R., Audicio, Paola F., Gambini, Juan P., Fernandez, Marcelo, Damian, Juan P., Moreno, Maria, Chabalgoity, Jose A., Alonso, Omar, Benech, Juan C., Cabral, Pablo

“…Scintigraphy image of normal (a) and melanoma-bearing mice (b) injected with 99mTc(CO)3-dendrimer-FITC, 1h post-injection. (a) White and yellow arrows point…”
Get full text

Development of super(99mTc(CO)) sub(3)-dendrimer-FITC for cancer imaging by Tassano, Marcos R, Audicio, Paola F, Gambini, Juan P, Fernandez, Marcelo, Damian, Juan P, Moreno, Maria, Chabalgoity, Jose A, Alonso, Omar, Benech, Juan C, Cabral, Pablo

“…Study of fluorophore and technetium labeling of poly(amido)-amine (PAMAM) generation 4 (G4) dendrimer and its evaluation as potential molecular imaging agent…”
Get full text

[[super]177Lu]DOTA-anti-CD20: Labeling and pre-clinical studies by Audicio, Paola F, Castellano, Gustavo, Tassano, Marcos R, Rezzano, Maria E, Fernandez, Marcelo, Riva, Eloisa, Robles, Ana, Cabral, Pablo, Balter, Henia, Oliver, Patricia

“…Anti-CD20 (Rituximab[super][registered]), a specific chimeric monoclonal antibody used in CD20-positive Non-Hodgkin's Lymphoma, was conjugated to a…”
Get full text